Stay updated with breaking news from Daniel Geynisman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Due to a recent influx of prostate cancer diagnoses, doctors are urging men in their 40s to get screened early to potentially save your life later.
First presentation of results from Phase 3 CheckMate -67T trial with subcutaneous formulation of Opdivo to be shared in a late-breaking oral presentation Four-year data from CheckMate -9ER and...
Complete clinical response predicted favorable outcomes for up to 2 years
Data from a real-world study support nivolumab + ipilimumab as first-line treatment for intermediate- or poor-risk mRCC.
/PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced a collaboration with Pfizer and Myovant...